Some hospitals in the United States are marking up costs approximately 10 times the Medicare-allowed costs. This equals a markup of more than 1000% for the same medical services.
Some hospitals in the United States are marking up costs approximately 10 times the Medicare-allowed costs, according to a study published in Health Affairs. This equals a markup of more than 1000% for the same medical services.
The researchers examined the 50 hospitals with the highest charge-to-cost ratios in 2012. Of the hospitals analyzed, 49 are for-profit systems and 20 are operating in Florida. In addition, 1 for-profit hospital system owns half of the hospitals.
“For-profit hospitals appear to be better players in this price-gouging game,” Ge Bai, PhD, assistant professor of accounting at Washington and Lee University, said in a statement. “They represent only 30% of hospitals in the US, but account for 98% of the 50 hospitals with highest markups."
According Dr Bai, while the markup effect trickles down to every consumer, the effect is worse for vulnerable populations.
She and colleague Gerard F. Anderson, PhD, a professor in the Department of Health Policy and Management and the Department of International Health at the Johns Hopkins Bloomberg School of Public Health, analyzed the 2012 Medicare cost reports from CMS. The charge-to-cost ratio is an indicator of how much hospitals are marking up charges beyond what Medicare agrees to pay for its consumers.
These 50 hospitals may be the worst offenders, but they are not alone. Typically a hospital in the US charges an average of 3.4 times the Medicare-allowable cost.
“There is no justification for these outrageous rates, but no one tells hospitals they can’t charge them,” Dr Anderson said. “For the most part, there is no regulation of hospital rates and there are no market forces that force hospitals to lower their rates. They charge these prices simply because they can.”
Although there is no federal law that regulates the rates hospitals can charge for services, Maryland and West Virginia do have state-set rates.
“Federal and state governments may want to consider limitations on the charge-to-cost ratio, some form of all-payer rate setting, or mandated price disclosure to regulate hospital markups,” the authors wrote.
Data analysis showed that 40% of patients who filled a prescription for Wegovy in 2021 or 2022 were still taking it a year later; both Democrats and reproductive rights organizations are pressuring the Biden administration to ensure health insurers fully cover contraception; CMS implemented Medicare changes in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More